Triphala has never been scientifically studied for its anticancer,
cytoprotective, antimutagenic, immunomodulatory,
or chemopreventive effects in humans. Pilot studies with a
small number of healthy individuals should be initially
performed to understand the maximum tolerable dose.
Later, trials to validate the experimentally observed anticancer,
radioprotective, chemoprotective, and chemopreventive
effects need to be performed as then the efficacy will
be clearly understood.